Predicting methylphenidate response in ADHD using machine learning approaches.

Predicting methylphenidate response in ADHD using machine learning approaches.

Int J Neuropsychopharmacol. 2015 May 10;

Authors: Kim JW, Sharma V, Ryan ND

Abstract
BACKGROUND: There are no objective, biological markers that can robustly predict methylphenidate (MPH) response in ADHD. This study aimed to examine whether applying machine learning approaches to pre-treatment demographic, clinical questionnaire, environmental, neuropsychological, neuroimaging, and genetic information can predict therapeutic response following MPH administration.
METHODS: The present study included 83 ADHD youth. At baseline, parents completed the ADHD Rating Scale IV and Disruptive Behavior Disorder rating scale (DBD), and participants undertook the continuous performance test, Stroop color word test (SCWT), and resting-state functional MRI scans. The dopamine transporter gene, dopamine D4 receptor gene, alpha-2A adrenergic receptor gene (ADRA2A) and norepinephrine transporter gene polymorphisms, and blood lead and urine cotinine levels were also measured. The participants were enrolled in an 8 week, open-label trial of MPH. Four different machine learning algorithms were used for data analysis.
RESULTS: Support vector machine (SVM) classification accuracy was 84.6% (area under receiver operating characteristic curve (AUC) 0.84) for predicting MPH response. The age, weight, ADRA2A MspI and DraI polymorphisms, lead level, SCWT performance, and oppositional symptoms of DBD were identified as the most differentiating subset of features.
CONCLUSIONS: Our results provide preliminary support to the translational development of SVM as an informative method that can assist in predicting treatment response in ADHD, though further work is required to provide enhanced levels of classification performance.

PMID: 25964505 [PubMed – as supplied by publisher]

via http://ift.tt/1ED1LnJ